Patent Granted for PolypDx™ in Europe
![](/public/uploads/images/europeanpatentoffice/1579094885-330w_europeanpatentoffice.jpg)
Metabolomic Technologies Inc. has been granted a patent for its PolypDx™ technology by the European Patent Office. PolypDx™ received patent approval in Japan in September, 2015, and in Australia in February, 2017. Patents are also pending in the US, Canada and Hong Kong.